Winstrol 10 mg 50 Capsules Atlas Labs.
$65.00
Product Short Description
Winstrol 10 mg 50 Capsules Atlas Labs delivers stanozolol (C21H32N2O), the pyrazole-ring modified DHT anabolic steroid, at pharmaceutical-equivalent 10 mg potency in capsule form matching DEA Schedule III controlled substance standards. Domestic production serves institutional performance channels exclusively.
Product Overview
Atlas Labs’ Winstrol 10 mg presents stanozolol, exhibiting high anabolic:androgenic ratio (~320:30) characteristic of 17α-methylated DHT derivatives with pyrazole substitution preventing aromatization, in precision-filled capsules for institutional catalogs. The 50-capsule tamper-evident configuration supports CIII-compliant inventory management across encrypted specialist platforms requiring batch traceability essential for DEA-regulated workflows.
U.S. domestic manufacturing eliminates customs exposure while maintaining USP-equivalent specifications distinguishing legitimate Schedule III supply from underground tablet presses. Capsule delivery provides alternative to traditional scored tablets serving advanced resellers managing controlled substance inventories.
Winstrol targets verified CIII ecosystems emphasizing commercial positioning without protocols or claims.
Brand & Manufacturer Information
Atlas Labs produces Schedule III anabolics through domestic facilities serving institutional performance distribution requiring controlled substance compliance. Winstrol 10 mg capsules maintain catalog continuity alongside Atlas Dianabol with capsule format distinguishing from tablet competitors while authenticating legitimate institutional supply.
Domestic warehousing supports DEA Form 222 record-keeping confirming stanozolol identity/potency across encrypted platforms.
Active Compound Information
Contains stanozolol (17α-methyl-2’H-5α-androst-2-enopyrazol-17β-ol), heterocyclic DHT derivative featuring pyrazole ring fusion at C2-C3 positions enabling extreme anabolic potency with ~8-hour half-life and no estrogen conversion. DEA Schedule III (21 CFR 1308.13) classification reflects hepatotoxicity profile characteristic of 17α-methylated oral steroids.
10 mg strength matches discontinued Winstrol prescription while 50-capsule count supports institutional packaging. WADA S1a prohibited globally.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Winstrol 10 mg 50 Capsules Atlas Labs |
| Active Compound | Stanozolol (C21H32N2O) |
| Strength | 10 mg per capsule |
| Quantity | 50 capsules per bottle |
| Form | Oral capsules |
| Category | DEA Schedule III controlled substance |
| Packaging | Tamper-evident HDPE bottle |
| Label Elements | 10 mg declaration, batch code, CIII warnings |
Quality Control & Testing Standards
10 mg stanozolol capsules require USP potency assay (90-110% HPLC), content uniformity, and capsule dissolution verification confirming pharmaceutical-grade fill weight. Atlas batch documentation verifies C21H32N2O identity and Schedule III-compliant excipients distinguishing legitimate production from underground alternatives.
50-capsule institutional bottling prevents diversion matching DEA protocols; capsule format enhances bioavailability consistency versus compressed tablets.
Intended Use & Market Positioning
Serves CIII-licensed institutional researchers managing DEA Schedule III oral anabolic inventories exclusively. 10 mg/50-cap configuration positions within verified domestic catalogs serving licensed clientele. No protocols represented.
Legal & Regulatory Disclaimer
Stanozolol constitutes DEA Schedule III under 21 USC §812; non-medical handling violates Controlled Substances Act. Buyer assumes Form 222 compliance; zero medical claims provided.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.